| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.051 | 0.6 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |